EarliPoint Autism Assessment2026-04-28T12:25:45-04:00

EarliPoint Autism Assessment at CompleatKiDZ

Earlier Answers.
Clearer Next Steps.

Autism Evaluations for Children as Young as 16 Months

Child watching EarliPoint eye-tracking screen during autism assessment at CompleatKiDZ clinic

A Better Way to Understand Your Child’s Development

At CompleatKiDZ, we provide quick, engaging developmental assessments designed to help families better understand how their child is growing and learning.

During a 12 minute child-friendly experience, your child watches short video scenes while advanced, EarliPoint® eye-tracking technology measures how they respond to social and visual information.

These insights give our clinical team a deeper understanding of how your child engages, communicates, and processes the world around them — helping guide clear, personalized next steps.

With clinically proven accuracy, EarliPoint delivers objective data that helps families move forward with greater confidence and clarity.

Available at select locations in North Carolina, South Carolina and Virginia

What is an Eye-Tracking Video Assessment?

EarliPoint is the first and only FDA-cleared system* that measures how a child visually engages with the world, providing objective insights that support autism assessment.

Using advanced eye-tracking technology, EarliPoint analyzes how children look at social interactions and environments, helping clinicians better understand developmental patterns that may be associated with autism.

During the assessment:

  • Your child watches short video scenes on a screen for 12 minutes
  • Eye-tracking technology measures where they naturally look
  • Results are generated same day and shared with our in-house psychologist
Earlipoint Logo

Understand Your Child’s Development

Support, clarity, and next steps—powered by advanced, FDA-cleared technology.

FDA-cleared assessment technology paired with our in-house clinicians helps identify early signs of autism—so you don’t have to wait months for clarity.

EarliPoint provides objective insights into how your child pays attention, engages, and learns—giving you a deeper understanding of their unique development.

See how your child is growing with repeatable assessments that measure progress and help guide therapy decisions every step of the way.

Designed for Real Life, Not Just the Clinic

Your child simply watches short, engaging videos—no pressure, no complicated tasks.
Just meaningful insights that help guide the next step forward.

Backed by Proven Research

EarliPoint isn’t experimental — it’s built on decades of science and validated in large-scale clinical studies.

  • Published in the Journal of the American Medical Association (JAMA)
  • Based on multiple large, double-blind clinical trials
  • Demonstrated strong accuracy compared to expert clinical diagnosis
  • Measures real-time behavior as a biomarker of autism

Research shows that patterns in how children visually engage with faces, motion, and social cues can reliably predict developmental differences — giving clinicians powerful, objective data to support decision-making.

FAQs

What happens after the evaluation?2026-04-21T13:17:09-04:00

You’ll review results with a clinician and discuss next steps, which may include therapy, further evaluation, or monitoring progress.

Is the test safe?2026-04-21T13:16:46-04:00

Yes. It is completely non-invasive — your child simply watches videos while the system tracks eye movement.

How long does the assessment take?2026-04-21T13:16:27-04:00

The viewing portion typically takes about 15 minutes, with additional time for setup and review.

How early can my child be tested?2026-04-21T13:16:03-04:00

EarliPoint is designed for children as young as 16 months who are at risk based on developmental concerns.

Is EarliPoint a diagnosis?2026-04-21T13:15:38-04:00

No. EarliPoint is a tool that provides objective data to support clinicians. A qualified provider makes the final diagnosis

The EarliPoint Assessment device is a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months through 95 months (7 years) who are at risk based on concerns identified by a parent, caregiver, or healthcare provider.

*EarliPoint is currently FDA-cleared for use in select states, with additional approvals anticipated in the future. At this time, EarliPoint is not FDA-cleared in the state of North Carolina. At CompleatKiDZ, this technology is utilized as a supplemental tool to provide valuable data that supports initial psychological evaluations and helps inform ongoing developmental benchmarking throughout a child’s care plan. It is not used as a standalone diagnostic instrument.

Go to Top